The undersigned organizations write to express our concern that FDA has yet to issue any decisions on applications for marketing orders for menthol-flavored e-cigarettes or e-liquid products. We believe granting any such orders would be inconsistent with the agency’s marketing denial orders for other non-tobacco flavored products and would be harmful to public health, particularly to the health of young people.
Breast Cancer Screening Helps Save Lives
Breast cancer is the most commonly diagnosed cancer and the second-leading cause of cancer death in women. In 2022, an estimated 287,850 women and 2,710 men will be diagnosed with invasive breast cancer, and approximately 43,250 women and 530 men are expected to die from the disease. Although incidence rates have increased slightly over the past decade, death rates from breast cancer have been consistently declining over the last three decades, largely due to increased screening rates and improved treatment.